February 27, 2019
In this 2019 video, Dr. Yilmaz talks about the updated CAP protocols for testicular cancer, and updates to the WHO and TNM classification systems
Watch as Dr. Asli Yilmaz talks about updates to the CAP checklists for testicular tumours as well as updates to the AJCC TNM staging system and WHO classification. She talks about testicular germ cell tumours (TGCT) as well as diagnostic challenges and pitfalls in the context of this disease’s increasing incidence rates.
CAP education session about testicular cancer
About the presenter, Dr. Asli Yilmaz
Asli Yilmaz, MD, FRCPC, is an Associate Professor in the Pathology & Laboratory Medicine department at the University of Calgary in Calgary, Alberta, Canada. She completed her residency training in Anatomical Pathology with a Surgical Pathology fellowship at Ohio State University in Columbus, Ohio, U.S.A. She also completed a year of Oncological Pathology at Memorial Sloan Kettering in New York and did additional training there in Urinary Pathology. She serves as a Uropathology Specialist and Consultant for the Southern Alberta Institute of Urology and for the Tom Baker Cancer Centre in Calgary.
About the CAP education sessions
The Partnership, the Canadian Association of Pathologists (CAP-ACP), and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.